Search

Ethnopharmacological Relevance: Bridelia ferruginea Benth. (Euphorbiaceae) is among the medicinal plants commonly used for the management of type 2 diabetes (T2D) and its complications., Aim of the Study: The hepato-therapeutic effect of the butanol fraction of Bridelia ferruginea leaves was investigated in diabetic rats., Methods: The butanol fraction of B. ferruginea was given to type 2 diabetic rats at both low and high doses (150 and 300 mg/kg bodyweight, respectively), while metformin and glibenclamide served as the standard anti-diabetic drugs. A normal toxicological group was administered a high dose of the fraction. At the end of the experimental period, the rats were sacrificed, and their livers and psoas muscle collected. The liver was assayed for oxidative stress markers, liver glycogen content, lipid metabolite profile (using GC-MS) and their metabolic pathways were analyzed using the MetaboAnalyst 5.0 online server. The expression of GLUT4 was also assayed in the liver and muscle as well as the identification of signaling pathways associated with GLUT4 expression using the Enrichr online server. In silico molecular docking was used to investigate the molecular interactions of some postulated compound found in B. ferruginea with GLUT4. The ability of the fraction to stimulate muscle glucose uptake was determined in isolated rat psoas muscle ex vivo., Results: Treatment with the high dose of fraction caused an inhibition of lipid peroxidation as well as the elevation of catalase, SOD, glutathione reductase and glutathione peroxidase activities in the rat liver. There was an increased expression of GLUT4 in livers and muscles of diabetic rats following treatment with B. ferruginea. Treatment with the fraction also caused inactivation of diabetes-activated pathways and changes in the distribution of the hepatic lipid metabolites. Molecular docking analysis revealed strong molecular interactions of pyrogallol and sitosterol with GLUT4., Conclusions: These data illustrate the hepato-protective effect of B. ferruginea in diabetic rats which compare favorably with the tested anti-diabetic drugs (metformin and glibenclamide)., (Copyright © 2021 Elsevier B.V. All rights reserved.)

Background We investigated the effects of a polyherbal formulation prepared from the extracts of Mondia whitei (Periplocaceae), Dracaena arborea (Dracaenaceae), and Bridelia ferruginea (Euphorbiaceae) (MDB) on the sexual behavior of normal rats (NR) and prediabetic rats (PR). Methods Male Wistar rats were administered with drinking fructose solution (21%) or tap water for 16 weeks. After induction of prediabetic status, NR (n = 30) and PR (n = 30) were randomly distributed into 10 groups of six animals each and orally treated with distilled water (10 mL/kg), sildenafil citrate (5 mg/kg), or MDB (50, 100, or 500 mg/kg) for 21 days. Sexual behavior parameters per series (S) of ejaculation were evaluated on days 1, 7, 14, and 21. Results Drinking fructose solution (21%) induced prediabetic status in rats, characterized by a significant (p < 0.01) increase in glycemia by 43.41% compared with the control group. MDB improved sexual performances of NR and PR by increasing the mount frequency (MF) and the intromission frequency (IF) as well as the number of rats capable of ejaculating. For instance, the MF and the IF were significantly increased in animals administered with MDB for 7 (50 mg/kg, S1 and S2), 14 (100 mg/kg, S3), or 21 days (100 or 500 mg/kg, S2). This increase was more pronounced on days 7 and 14 in NR and PR treated with sildenafil citrate or MDB extracts, respectively. Conclusions The mixture of MDB improved sexual activity in NR and PR. This result may further justify the traditional use of these plants as sexual performance enhancers.

Ethnopharmacological Relevance: The root of Bridelia ferruginea is traditionally used as a treatment for type 2 diabetes. The present study was investigated to evaluate the effect of Bridelia ferruginea root bark fractions on some markers of type 2 diabetes on fructose drinking mice., Materials and Methods: Mice received a solution of fructose 15% during 42 days ad libitum; at the 15th day to the 42nd day, they received distilled water for fructose drinking control group, metformin 50 mg/kg per day or fractions 50 mg/kg per day for treatment groups. The normal control group received only distilled water during the experiment. After 6 weeks of experiment, OGTT, fasting blood glucose, plasma insulin, triglycerides (TG), total cholesterol, AST and ALT levels were measured., Results: Fructose drinking control group (F) showed significant (p<0.001) increase of glucose tolerance, plasma levels of total cholesterol, triglycerides and insulin index for insulin resistance (Homeostasis Model Assessment ratio HOMA-IR) as compared to normal control mice. In treated groups, there was a significant reduction of glucose intolerance respectively 74% (p<0.001), 25% (p<0.5) and 92% (p<0.001) for ethyl acetate fraction, acetone fraction and metformin at the same dose of 50 mg/kg per day during 4 weeks administration. In ethyl acetate fraction and metformin treated groups, biochemical parameters and insulin index were significantly (p<0.001) lower than that of fructose drinking control group., Conclusions: This indicates that Bridelia ferruginea root bark ethyl acetate fraction improved insulin resistance as metformin significantly in type 2 diabetes., (Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.)

Abstract: The present investigation was carried out to evaluate the safety of hydro-ethanol extract of Bridelia ferruginea Benth (Euphorbiaceae) root bark. For acute toxicity study, a single dose of 2000 and 5000mg/kg of the B. ferruginea root bark extract was given orally to healthy male Wistar rats and Balb/c mice. The animals were observed for mortality and clinical signs for 3h and then daily for 14days. In the sub-chronic toxicity study, the extract was administered orally at doses of 250, 500 and 1000mg/kg/day for 28days to male Wistar rats. Animals were sacrificed to examine their organs, and urine and blood serum were analyzed. In the acute toxicity study, B. ferruginea root bark extract caused neither significant visible signs of toxicity, nor mortality in Wistar rats and Balb/c mice. In sub-chronic toxicity study, administration of the B. ferruginea root bark extract at 250, 500, and 1000mg/kg for 28 consecutive days to Wistar rats did not produce mortality. No significant differences were found in relative organ weights, biochemical studied parameters in treated groups compared to control group. No obvious histological changes were observed in organs of B. ferruginea extract treated animals compared to controls. [Copyright &y& Elsevier]

Purpose: To evaluate the hypoglycaemic effect of the methanol extract of Bridelia ferruginea leaves (MEBF) on sucrose-induced glucose intolerance in rats. Methods: Male Wistar rats, aged 6 - 7 weeks and weighing 140 - 160 g, were used. The animals were fed standard rat chow supplemented with 35%, 50% or 65% sucrose for 8 weeks while control animals were fed standard rat chow. The hypoglycaemic effect of MEBF and the reference drugs (tolbutamide, and metformin) in the animals were evaluated following a single dose of these drugs and 6-day treatment. Plasma lipid profiles were also determined. Results: Fasting glucose concentrations ranged from 45 to 70 mg/dl, and the increase was significant in the sucrose diet groups from week 1. After 2 weeks on these diets, oral glucose tolerance test showed that sucrose feeding significantly impaired glucose homeostasis 1 and 2 hours after a glucose challenge (76.7 ? 2.0 versus 86.4 ? 8.5 and 66.7 ? 1.4 versus 75.5 ? 3.0, respectively). Fasting blood sugar levels were significantly (p < 0.05) reduced in sucrose-induced, glucose-intolerant rats after a single dose of MEBF. The extract also significantly reduced blood glucose (from 167 ± 23 mg/dL to 126 ± 5 mg/dL), serum total cholesterol (from 161 ± 20 mg/dL to 93 ± 10 mg/dL) and triglyceride levels (281 ± 25 mg/dL to 228 ± 5 mg/dL) in glucose intolerant rats after 6 days of treatment. Conclusion: The methanol leaf extract of Bridelia ferruginea exhibited hypoglycaemic effect in glucoseintolerant rats. [ABSTRACT FROM AUTHOR]

Purpose: To characterize some preformulation properties of aqueous stem bark extract of Bridelia ferruginea Benth (Euphorbiaceae) (BF). Methods: The stem bark was extracted by maceration in hot distilled water. Two batches of granules containing the extract were prepared by wet granulation using maize starch, polyvinylpyrrolidone (PVP), Avicel® PH-101, magnesium stearate, acacia and lactose as excipients. Some physicochemical and micromeritic properties of the powdered extract and granules were determined following standard procedures. Results: The pH of the aqueous BF extract was 5.4 ± 0.1 while the moisture content of the dry extract was 12.0 %. Total ash value of the extract was 7.91 ± 0.03. Particle size increased after granulation from 228 to 531 µm in the order: granules 1 > granules 2 > powder. The bulk and tapped densities decreased significantly (p < 0.05) from 0.40 ± 0.04 to 0.77 ± 0.09 and 0.49 ± 0.05 to 0.85 ± 0.09 g/ml, respectively in the order: granules 2 < granules 1 < powder. Similarly, the angle of repose increased after granulation from 24.0 ± 0.5 to 25.4 ± 0.9 o in the order: granules 2 < granules 1 < powder (p < 0.05). The flow rate and compressibility of the granules (2.45 ± 0.08 g/min and 0.17, respectively) improved significantly (p < 0.05) over those of the powdered BF extract (2.34 ± 0.05 g/min and 0.26, respectively). Conclusion: The results of this preformulation study indicates that the powdered extract of Bridelia ferruginea possesses properties that make it suitable for its formulation into standard solid dosage forms. [ABSTRACT FROM AUTHOR]

Objectives: Bridelia ferruginea Benth (Euphorbiaceae) is a plant, which is used in traditional medicine in Africa to treat many diseases. In this study, we want to further investigate the effects of an aqueous extract of Bridelia ferruginea stem bark (SEA) on the contractile activity of the isolated aorta of guinea-pig. Methods: Isolated aorta obtained from guinea-pig was placed in physiological solution (Mac Ewen). Experiments were performed in preparations suspended between two L-shaped stainless steel hooks in a 10 ml organ bath containing Mac Ewen solution. The isometric contractile force of the aorta strips of guinea-pig were recorded by using a strain gauge. Some experiments were performed on the resting baseline of the endothelium intact as well as denuded preparations. Results: The effects of an extract of Bridelia ferruginea (SEA) were studied on the isolated aorta of guinea pig. SEA (10-2 - 3.10-1 mg/ml) induced vasorelaxation effect in concentration dependent as acetylcholine. The vasorelaxant effects of SEA in the isolated, endothelium-intact aortic were significantly reduced after the pre-treatment with L-NNA (10-6 mg/ml) and diclofenac (10-6 mg/ml) which are respectively a nitric oxide synthase inhibitor and cyclooxygenase inhibitor. SEA as acetylcholine did not relax endothelium-denuded aortic preparations. The both substances induced vasoconstrictions on this preparation. Conclusion: The vasorelaxant action of SEA is endothelium dependent, and is, therefore, possibly dependent on the synthesis and release of nitric oxide (NO) and cyclooxygenase, according to response observed in the presence of L-NNA and diclofenac. [ABSTRACT FROM AUTHOR]

Abstract: Objective: The objective of this work was to determine the beta-amyrin acetate fraction in leave extract of Bridelia ferruginea and evaluate for its antioxidant and cytotoxicity potentials. Methods: The dried and pulverized leaves of Bridelia ferruginea was extracted with hexane and then with ethyl acetate. The concentrated ethylacetate extract subjected to silica gel column chromatography and eluted with a mixture of equal volume of hexane and dichloromethane afforded two major fractions. The more polar fraction was concentrated and subjected to GCMS analysis which afforded the steroid, 12-Oleanen-3yl acetate commonly known as beta-amyrin acetate (66.14%). Its ability to act as a scavenger of DPPH radical and its cytotoxicity potential based on brine shrimp assay were investigated. Results: The DPPH antioxidant assay revealed that the fraction had a higher antioxidant potential with an IC50 value of 158.2μg/mL relative to gallic acid which had IC50 of 201.1 μg/mL. The cytotoxicity assay using the brine shrimp a gave LC50 values of 319 and 5.86 μg/mL for acute and lethal doses respectively indicating extreme toxicity when compared to reference drug, cyclophosphamide which had LC50 value of 2506 μg/mL. Conclusions: Thus, the beta-amyrin acetate has been identified for the first time in the leave of Bridelia ferruginea. The data here suggest that the beta-amyrin acetate fraction of the leave of Bridelia ferruginea could be further explored in biological profiling requiring antioxidant and cytotoxic dependent therapeutics as the plant could be a viable source of antioxidant and cytotoxic agents in cancer chemotherapy in the near future. [Copyright &y& Elsevier]